KEGG   PATHWAY: nvs04650
Entry
nvs04650                    Pathway                                
Name
Natural killer cell mediated cytotoxicity - Neogale vison (American mink)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
nvs04650  Natural killer cell mediated cytotoxicity
nvs04650

Other DBs
GO: 0042267
Organism
Neogale vison (American mink) [GN:nvs]
Gene
122889094  [KO:K04726]
122889339  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
122889648  PTK2B; protein-tyrosine kinase 2-beta isoform X1 [KO:K05871] [EC:2.7.10.2]
122889778  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
122889990  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
122890898  KLRD1; natural killer cells antigen CD94 [KO:K06516]
122890900  [KO:K06541]
122890901  [KO:K06541]
122890902  [KO:K06541]
122891140  [KO:K06541]
122891375  IFNG; interferon gamma [KO:K04687]
122891446  [KO:K06541]
122891457  [KO:K06728]
122891540  BID; BH3-interacting domain death agonist [KO:K04726]
122891553  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860]
122891588  [KO:K06541]
122891921  PTPN6; tyrosine-protein phosphatase non-receptor type 6 isoform X1 [KO:K05697] [EC:3.1.3.48]
122891987  [KO:K06541]
122892109  [KO:K06541]
122892446  KRAS; GTPase KRas isoform X1 [KO:K07827]
122892965  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
122892978  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]
122893137  [KO:K01353] [EC:3.4.21.79]
122893234  SHC4; SHC-transforming protein 4 isoform X1 [KO:K17449]
122894274  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
122894512  [KO:K01353] [EC:3.4.21.79]
122895342  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
122895504  LAT; linker for activation of T-cells family member 1 [KO:K07362]
122895627  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
122895632  [KO:K05718]
122895665  [KO:K05718]
122895963  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
122896188  LAT2; linker for activation of T-cells family member 2 [KO:K26356]
122896803  SH2D1A; SH2 domain-containing protein 1A [KO:K07990]
122897579  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
122898126  [KO:K07986]
122898230  [KO:K07986]
122898640  LCK; tyrosine-protein kinase Lck [KO:K05856] [EC:2.7.10.2]
122898897  [KO:K07986]
122898912  PRF1; perforin-1 [KO:K07818]
122899136  [KO:K07828]
122899425  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
122899821  RAET1E; LOW QUALITY PROTEIN: retinoic acid early transcript 1E [KO:K07987]
122899916  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
122899945  TNF; tumor necrosis factor isoform X1 [KO:K03156]
122900262  VAV3; guanine nucleotide exchange factor VAV3 [KO:K05730]
122900359  NRAS; GTPase NRas [KO:K07828]
122900656  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
122900795  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
122900952  NCR2; natural cytotoxicity triggering receptor 2 [KO:K06742]
122901067  [KO:K07986]
122901675  CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427]
122902796  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
122903200  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
122903412  PTPN11; tyrosine-protein phosphatase non-receptor type 11 isoform X1 [KO:K07293] [EC:3.1.3.48]
122903454  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
122905138  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
122905414  [KO:K07986]
122905874  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
122905991  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
122906063  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
122906081  ICAM2; intercellular adhesion molecule 2 [KO:K06523]
122906241  IFNGR1; interferon gamma receptor 1 [KO:K05132]
122906355  NCR3; natural cytotoxicity triggering receptor 3 [KO:K06743]
122908229  ITGB2; integrin beta-2 [KO:K06464]
122908329  IFNGR2; interferon gamma receptor 2 isoform X1 [KO:K05133]
122908330  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
122908332  IFNAR2; interferon alpha/beta receptor 2 isoform X1 [KO:K05131]
122908700  TNFSF10; tumor necrosis factor ligand superfamily member 10 [KO:K04721]
122908712  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
122908899  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
122909192  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
122909588  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
122909740  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
122909813  VAV1; proto-oncogene vav [KO:K05730]
122909871  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
122909991  SHC2; SHC-transforming protein 2 isoform X1 [KO:K17447]
122911198  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859] [EC:3.1.4.11]
122911575  [KO:K07992]
122911685  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
122912199  [KO:K06741]
122912557  PAK1; serine/threonine-protein kinase PAK 1 [KO:K04409] [EC:2.7.11.1]
122913220  HRAS; GTPase HRas isoform X1 [KO:K02833]
122913256  [KO:K04722]
122915138  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
122915688  [KO:K07360] [EC:2.7.10.2]
122915966  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 [KO:K17332]
122916074  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
122916735  [KO:K05414]
122916921  [KO:K05414]
122916922  [KO:K05414]
122916923  [KO:K05414]
122916924  [KO:K05414]
122916925  [KO:K05414]
122916926  [KO:K05414]
122916927  [KO:K05414]
122916929  [KO:K05414]
122916930  [KO:K05414]
122916931  [KO:K05414]
122916932  [KO:K05414]
122916933  [KO:K05414]
122916934  [KO:K05414]
122916935  [KO:K05414]
122916936  [KO:K05414]
122916937  [KO:K05414]
122916938  IFNB1; interferon beta [KO:K05415]
122917100  VAV2; guanine nucleotide exchange factor VAV2 isoform X1 [KO:K05730]
122917394  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
122917563  [KO:K05414]
122917564  [KO:K05414]
122917799  SHC3; SHC-transforming protein 3 [KO:K17448]
122917804  SYK; tyrosine-protein kinase SYK isoform X1 [KO:K05855] [EC:2.7.10.2]
122917961  CD247; T-cell surface glycoprotein CD3 zeta chain [KO:K06453]
122918079  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
122918083  [KO:K06463]
122918084  [KO:K06463]
122918087  SH2D1B; SH2 domain-containing protein 1B [KO:K07989]
122918121  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
122918354  CD48; CD48 antigen [KO:K06479]
122918356  CD244; natural killer cell receptor 2B4 isoform X1 [KO:K06582]
122918946  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
122919099  SH3BP2; SH3 domain-binding protein 2 isoform X1 [KO:K07984]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
nvs04010  MAPK signaling pathway
nvs04020  Calcium signaling pathway
nvs04060  Cytokine-cytokine receptor interaction
nvs04210  Apoptosis
nvs04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system